Tumor conditioned medium could upregulate CXCL12 expression that facilitated the migration of human BM-MSCs to tumor sites by activating JAK2/STAT3 and MEK/ERK1/2 pathways [185]. The gene discussed is MAPK3; the disease is neoplasm.